Breaking News Instant updates and real-time market news.

APRN

Blue Apron

$5.02

-0.1208 (-2.35%)

, SNAP

Snap

$12.16

-1.614 (-11.72%)

10:36
08/11/17
08/11
10:36
08/11/17
10:36

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Blue Apron (APRN) was downgraded to Hold from Buy at SunTrust, to Neutral from Buy at Citi, and to Perform from Outperform at Oppenheimer. 2. Snap (SNAP) downgraded to Neutral from Buy at Monness Crespi. 3. Navios Acquisition (NNA) downgraded to Neutral from Buy at Citi with analyst Christian Wetherbee saying he is becoming more concerned about the sustainability of the company's dividend with existing charters rolling off in the coming four quarters, following the company's quarterly results. 4. Masonite (DOOR) downgraded to Hold from Buy at Stifel with analyst John Baugh saying Wednesday night's results marked the second consecutive quarter of disappointment on the top and bottom lines. 5. Hudson Technologies (HDSN) downgraded to Neutral from Buy at B. Riley with analyst Sarkis Sherbetchyan saying the shares are fairly priced following the company's second quarter report. The analyst raised his price target for the stock to $10 from $8.50. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

APRN

Blue Apron

$5.02

-0.1208 (-2.35%)

SNAP

Snap

$12.16

-1.614 (-11.72%)

NNA

Navios Acquisition

$1.34

-0.02 (-1.47%)

DOOR

Masonite

$57.33

-1.025 (-1.76%)

HDSN

Hudson Technologies

$9.26

1.3 (16.33%)

  • 11

    Aug

  • 14

    Aug

  • 21

    Aug

  • 13

    Sep

APRN Blue Apron
$5.02

-0.1208 (-2.35%)

08/11/17
RHCO
08/11/17
DOWNGRADE
RHCO
Hold
Blue Apron downgraded on 2H17 outlook at SunTrust
As noted earlier, SunTrust downgraded Blue Apron to Hold from Buy. Analyst Youssef Squali downgraded the stock based on what he sees as its "disappointing" 2H17 guidance, which includes guidance for a net loss of ($128M)-($121M). The analyst says that the weak guidance was caused by both cost and customer acquisition issues. Suqali also cited lack of visibility on "a full recovery and costs" as reasons for the downgrade. Target to $5.50 from $12.
08/11/17
ADAM
08/11/17
NO CHANGE
Target $11
ADAM
Buy
Blue Apron price target lowered to $11 from $14 at Canaccord
Canaccord analyst Michael Graham lowered his price target on Blue Apron to $11 from $14 following the company's Q2 report, its first as a public company. The analyst said its fulfillment issues, which caused a delay in scaling volume, are disappointing but viewed as temporary. He believes the stock's upside will be limited in the short-term and until the company provides evidence of better execution. Graham maintained his Buy rating on Blue Apron shares.
08/11/17
RBCM
08/11/17
NO CHANGE
RBCM
Blue Apron had 'solid' results, but acceleration delayed, says RBC Capital
RBC Capital analyst Mark Mahaney says that Blue Apron reported "solid" Q2 results. However, he thinks that the acceleration of the company's growth will come later than he previously expected. He cut his price target on the shares to $8 from $10 but keeps an Outperform rating on the stock.
08/11/17
NEED
08/11/17
NO CHANGE
Target $6.5
NEED
Buy
Blue Apron target cut to $6.50, Buy rating maintained at Needham
Needham analyst Kerry Rice lowered his price target on Blue Apron to $6.50 from $10 after the company gave disappointing second half guidance along with its Q2 report. While disappointed, he believes the negative news is reflected in the share price and once the company's Linden facility is fully ramped he expects revenue to reaccelerate and margins to improve. Rice keeps a Buy rating on Blue Apron shares.
SNAP Snap
$12.16

-1.614 (-11.72%)

08/11/17
RBCM
08/11/17
NO CHANGE
RBCM
'Way too early' to alter thesis on Snap, says RBC Capital
RBC Capital analyst Mark Mahaney says it's "way too early" to alter his positive thesis on Snap, since "most of the market is still up for grabs." He cut his price target on the shares to $20 from $31 but keeps an Outperform rating on the stock.
08/11/17
MONN
08/11/17
DOWNGRADE
MONN
Neutral
Snap downgraded to Neutral from Buy at Monness Crespi
08/11/17
STFL
08/11/17
NO CHANGE
STFL
Snap mix shift contributed to Q2 revenue miss, says Stifel
Stifel analyst Scott W. Devitt says "a primary driver" of Snap's Q2 revenue miss "was its ad buying mix shifting significantly to the recently launched API / self-serve platforms." He says the change "pressured" the company's ad prices, but he thinks it will "broaden" advertiser demand "over time." Devitt trimmed his price target on the name to $18 from $22 but keeps a Buy rating on the stock.
08/11/17
OPCO
08/11/17
NO CHANGE
Target $16
OPCO
Outperform
Snap price target lowered to $16 from $23 at Oppenheimer
Oppenheimer analyst Jason Helfstein lowered his price target for shares of Snap to $16 but keeps an Outperform rating on the name. Daily active user growth is stable, but the advertising ramp remains sluggish on the company's shift to auction-based pricing, Helfstein tells investors in a post-earnings research note.
NNA Navios Acquisition
$1.34

-0.02 (-1.47%)

08/18/16
EVER
08/18/16
DOWNGRADE
EVER
Hold
Navios Acquisition downgraded to Hold from Buy at Evercore ISI
08/11/17
SBSH
08/11/17
DOWNGRADE
Target $1.25
SBSH
Neutral
Navios Acquisition downgraded to Neutral from Buy at Citi
Citi analyst Christian Wetherbee downgraded Navios Acquisition and cut his price target for the shares to $1.25 from $2.00. Following the Q2 results, the analyst is becoming more concerned about the sustainability of the company's dividend with existing charters rolling off in the coming four quarters.
DOOR Masonite
$57.33

-1.025 (-1.76%)

08/11/17
WEDB
08/11/17
NO CHANGE
WEDB
Masonite weakness overdone, says Wedbush
Wedbush analyst Jay McCanless blames Masonite's (DOOR) Q2 miss on " a one-time issue, the acceleration of the new Home Depot (HD) program, and ...overly aggressive demand forecasting." The analyst thinks that Masonite will correct the logistical problems causing the Home Depot issue, but he believes that the aggressive demand forecasting could weigh on the company's gross margins through fiscal 2017 and fiscal 2018. He cut his price target on the shares to $70 from $85 but keeps a Buy rating on the stock.
08/11/17
BARD
08/11/17
NO CHANGE
Target $70
BARD
Outperform
Masonite price target lowered to $70 from $90 at Baird
Baird analyst Timothy Wojs lowered his price target on Masonite to $70 from $90 following disappointing Q2 results. The analyst said a culmination of internal issues were exacerbated by slower than expected volumes, leading to lower estimates. The analyst believes the internal issues are fixable and volume should normalize as competitive dynamics remain solid to favorable. Wojs maintained his Outperform rating on Masonite shares.
08/11/17
SIDC
08/11/17
DOWNGRADE
Target $60
SIDC
Masonite downgraded on disappointing volume trends at Stifel
Stifel analyst John Baugh downgraded Masonite to Hold from Buy and lowered his price target for the shares to $60 from $85. Wednesday night's results marked the second consecutive quarter of disappointment on the top and bottom lines, Baugh tells investors in a post-earnings research note. Amid disappointing volume trends and operational challenges, the analyst sees the stock doing little before the next quarter's release in November. JPMorgan this morning called Masonite's risk/reward attractive after yesterday's pullback.
08/11/17
JPMS
08/11/17
NO CHANGE
Target $70
JPMS
Overweight
Masonite risk/reward attractive after selloff, says JPMorgan
JPMorgan analyst Jason Marcus believes yesterday's 20% post-earnings selloff in shares of Masonite more than discounts the Q2 disappointment and creates an attractive risk/reward profile. The analyst expects volumes to improve slightly in the second half of 2017 against the company's scenario for flat sales, and for sales growth to accelerate in the first half of 2018. Marcus, however, expects the shares to remain under pressure over the next one-to-two quarters. He lowered his price target for Masonite to $70 from $83 and keeps an Overweight rating on the name.
HDSN Hudson Technologies
$9.26

1.3 (16.33%)

05/16/17
CHLM
05/16/17
NO CHANGE
Target $10
CHLM
Buy
Hudson Tech a likely beneficiary of refrigerant shortages, says Craig-Hallum
Craig-Hallum analyst Steven Dyer said his checks on certain HFC refrigerants indicate recent sharp price increases and his industry sources expect further hikes through the summer as supply shortages persist. Dyer, who sees the recent refrigerants price surge as likely to positively impact Hudson Technologies' revenue and margins, reiterates his Buy rating and $10 price target on the shares.
08/10/17
CHLM
08/10/17
NO CHANGE
Target $10
CHLM
Buy
Hudson Tech acquisition of Airgas-Refrigerants a game changer, says Craig-Hallum
Craig-Hallum analyst Steven Dyer notes that Hudson Technologies (HDSN) delivered "solid" quarterly results and announced a transformative acquisition of Airgas-Refrigerants, a subsidiary of Airgas (ARG). The analyst believes the addition of Airgas will double Hudson Technologies' annual revenue and importantly adds scale, enhances the geographic footprint and customer base, and is expected to be "highly accretive" over time. Given its comparable size and myriad financial and competitive benefits, Dyer believes it could be "a game changer." He reiterates a Buy rating and $10 price target on Hudson Technologies' shares.
08/11/17
RILY
08/11/17
DOWNGRADE
Target $10
RILY
Neutral
Hudson Technologies downgraded to Neutral from Buy at B. Riley
B. Riley analyst Sarkis Sherbetchyan downgraded Hudson Technologies to Neutral saying the shares are fairly priced following the company's Q2 report. The analyst raised his price target for the stock to $10 from $8.50.
03/13/17
RILY
03/13/17
INITIATION
Target $9
RILY
Buy
Hudson Technologies resumed with a Buy at B. Riley
B. Riley analyst Ian Corydon resumed coverage of Hudson Technologies with a Buy rating and $9 price target.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.